John Fletcher
Director/Board Member at SPECTRANETICS CORP
Profile
John Fletcher has helped Back Bay Group over more than a decade on numerous projects both as a consultant and as a principal investor.
John serves as the CEO of Fletcher Spaght Inc., (www.fletcherspaght.com) a management consulting firm he founded to provide strategy and financing assistance to new companies.
John is also a Founding Partner of Fletcher Spaght Ventures, the firm’s venture capital fund.
Prior to launching FSI in 1983, John was a Senior Manager at The Boston Consulting Group, managing client relationships in healthcare and high technology companies.
Previously, John was a Ph.D.
candidate and instructor in International Business at the Wharton School, University of Pennsylvania.
Prior to Wharton, John was a Captain and jet pilot in the U.S.
Air Force.
John holds an MA in Finance from the Wharton School, an MBA from Southern Illinois University, and a BA from George Washington University.
John is a current or past board member for many companies, including Axcelis, AutoImmune, GlycoFi, NMT Medical, Quick Study Radiology, Spectranetics and Panacos Pharmaceuticals.
John also serves on the Board of Overseers and Cardiology Council of Children’s Hospital of Boston, the Board of Advisors of the Boston University Photonics Center, the Whitehead Institute at MIT, the Thayer School of Engineering at Dartmouth College, and the School of Government and Business at George Washington University.
John Fletcher active positions
| Companies | Position | Start |
|---|---|---|
| SPECTRANETICS CORP | Director/Board Member | - |
Back Bay Management Consulting Group, Inc.
 Back Bay Management Consulting Group, Inc. Investment ManagersFinance Back Bay Management Consulting Group, Inc. (Back Bay Group) provides management consulting services. The company was founded by Ali Malihi and Robert Fein in 1997. The firm is headquartered in Boston, MA. | Consultant / Advisor | - |
Axcelis, Inc.
 Axcelis, Inc. Investment ManagersFinance Axcelis, Inc. is an Independent firm. Axcelis, Inc. is headquartered in. | Director/Board Member | - |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Director/Board Member | - |
Former positions of John Fletcher
| Companies | Position | End |
|---|---|---|
| NMT MEDICAL | Director/Board Member | - |
Quick Study Radiology, Inc.
 Quick Study Radiology, Inc. Miscellaneous Commercial ServicesCommercial Services Quick Study Radiology (OSR) was founded to meet the radiological needs of community hospitals, radiology and oncology practices and independent imaging centers across the United States. The company is to help these healthcare facilities improve the quality of their patient care. Community hospitals form the backbone of thousands of suburban and rural communities throughout the United States. Even in an era of increasing urbanization, these community healthcare centers provide primary care to a majority of U.S. patients. At QSR, the company believes the answer to each of these questions is yes. The company PACS, RIS and other radiological services allow patients at community hospitals to have their images read by the best radiologists in the country. The community hospitals can attract and retain better in-hospital talent and increase the efficiency of their radiology departments. And it made these improvements possible at a cost community hospitals can afford. Its pricing models reduce capital expenditures, while its technology requires no additional technical staff to install, maintain or support. Community hospitals are as vital to the health of its country's as it has ever been. At QSR, it works to make sure they remain that way. | Director/Board Member | - |
AutoImmune, Inc.
 AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA. | Director/Board Member | - |
Training of John Fletcher
| The Wharton School of the University of Pennsylvania | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Spectranetics LLC
 Spectranetics LLC Medical SpecialtiesHealth Technology Spectranetics Corp. develops, manufactures, markets, and distributes single-use medical devices used in invasive procedures in the cardiovascular system. The company was founded by Robert Golobic, Johan Sverdrup, and Richard T. Simko in 1984 and is headquartered in Colorado Springs, CO. | Health Technology |
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA. | Health Technology |
NMT Medical, Inc.
 NMT Medical, Inc. Medical SpecialtiesHealth Technology NMT Medical, Inc. is an advanced medical technology company. It designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. The company was founded in July 1986 and is headquartered in Boston, MA | Health Technology |
Quick Study Radiology, Inc.
Quick Study Radiology, Inc. Miscellaneous Commercial ServicesCommercial Services Quick Study Radiology (OSR) was founded to meet the radiological needs of community hospitals, radiology and oncology practices and independent imaging centers across the United States. The company is to help these healthcare facilities improve the quality of their patient care. Community hospitals form the backbone of thousands of suburban and rural communities throughout the United States. Even in an era of increasing urbanization, these community healthcare centers provide primary care to a majority of U.S. patients. At QSR, the company believes the answer to each of these questions is yes. The company PACS, RIS and other radiological services allow patients at community hospitals to have their images read by the best radiologists in the country. The community hospitals can attract and retain better in-hospital talent and increase the efficiency of their radiology departments. And it made these improvements possible at a cost community hospitals can afford. Its pricing models reduce capital expenditures, while its technology requires no additional technical staff to install, maintain or support. Community hospitals are as vital to the health of its country's as it has ever been. At QSR, it works to make sure they remain that way. | Commercial Services |
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Back Bay Management Consulting Group, Inc.
Back Bay Management Consulting Group, Inc. Investment ManagersFinance Back Bay Management Consulting Group, Inc. (Back Bay Group) provides management consulting services. The company was founded by Ali Malihi and Robert Fein in 1997. The firm is headquartered in Boston, MA. | Finance |
Axcelis, Inc.
Axcelis, Inc. Investment ManagersFinance Axcelis, Inc. is an Independent firm. Axcelis, Inc. is headquartered in. | Finance |
- Stock Market
- Insiders
- John Fletcher
